Astria Therapeutics, Inc. (ATXS)

Jan 26, 2026 - ATXS was delisted (reason: acquired by BCRX)

12.58

0.00 (0.00%)

Inactive · Last trade price on Jan 22, 2026

Astria Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-124.03	-94.26	-72.89	-51.83	-194.91	-37.3
Asset Writedown & Restructuring Costs	-	-	-	-	164.61	-
Loss (Gain) From Sale of Investments	-4.03	-5.61	-0.09	-	-	-
Stock-Based Compensation	15.9	13.04	6.31	4.55	3.36	1.39
Other Operating Activities	1.32	1.07	0.63	1.1	0.66	0.06
Change in Accounts Payable	-0.14	2.81	0.73	-0.77	-1.97	0.35
Change in Other Net Operating Assets	-8.05	1.74	-3.14	3.41	-1.91	3.02
Operating Cash Flow	-119.73	-81.21	-68.45	-43.53	-30.15	-32.49
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Capital Expenditures	-0.59	-0.33	-0.03	-0.09	-0.02	-0.03
Cash Acquisitions	-	-	-	-	6.47	-
Investment in Securities	135.7	-191.54	135.08	-167.04	-19	6.33
Investing Cash Flow	135.11	-191.86	135.05	-167.13	-12.56	6.3

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Issuance of Common Stock	0	157.2	88.4	144.72	104.28	40.86
Financing Cash Flow	0	157.2	88.4	144.72	104.28	40.86

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Cash Flow	15.38	-115.87	155.01	-65.94	61.58	14.68

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Free Cash Flow	-120.32	-81.54	-68.47	-43.62	-30.17	-32.52
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-17042.92%	-	-	-	-	-
Free Cash Flow Per Share	-2.07	-1.45	-2.27	-2.98	-3.38	-10.63
Levered Free Cash Flow	-80.49	-52.58	-36.52	-25.02	-16.71	-18.79
Unlevered Free Cash Flow	-80.49	-52.58	-36.52	-25.02	-16.71	-18.79

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Change in Working Capital	-8.89	4.54	-2.41	2.65	-3.88	3.37

SEC Filings: 10-K · 10-Q